International: 1 514 272.7011Skype: thebreastcoursefacebooklinkedIn
The Breast Practices
Three doctors

Breast diseases:
detection, intervention
and therapy

DemonstrationPractical usagesConference


Exhibitors - look up our visibility package here

" Just a small note to tell how much I appreciated to participate in your event as an exhibitor. The ambiance was really pleasant throughout the event and everyone was helpful. In one word, congratulations and thank you."

- Mrs. S. K., Products Marketing Manager




Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. At Hologic, we are on a mission: to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design, every investment we make. Hologic is a market leader in mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging, and molecular diagnostic products including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. We are proud of our achievements and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company. Our core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health


Bard At Bard Biopsy Systems we are committed to helping physicians deliver uncompromised care for every patient - from breast biopsy to therapy. We understand the challenges physicians face in delivering superior care for their patients at all stages of treatment. Our technology, service and product development is directed toward finding solutions to these challenges that make it easier and more efficient for physicians to take patient care to a higher level. The 2010 acquisition of SenoRx completed a portfolio of biopsy, tissue marker, and therapy devices unmatched in the field. This broad line of category leading products ensures that physicians always have the best product for the challenge before them - without the need to compromise. Our customers can confidently enjoy the benefits of partnering with a single, trusted source, secure in knowing that no matter which Bard product they choose, they are choosing the best in its class. Bard Biopsy Systems proudly supports the breast cancer community through sponsorship of activities such as the American Cancer Society's "Making Strides Against Breast Cancer Walk." Based in Tempe, Arizona, Bard Biopsy Systems has sales operations throughout North America, Europe, Australia, Latin America and Asia. Bard Biopsy Systems is a business unit of Bard Peripheral Vascular, Inc., one of five divisions of C. R. Bard, Inc. For over 100 years, C. R. Bard has committed its resources to creating innovative products and services that meet the needs of healthcare providers and patients.
Biopsy Sciences Biopsy Sciences manufactures and markets the HydroMARK line of Breast Biopsy site markers. The HydroMARK breast biopsy site marker uses an proprietary material to substantially increase visibility using Ultrasound. The hydrogel absorbs fluids from the biopsy site and after hydration is more than 90% water. The HydroMARK is a water-soluble polyethylene glycol based hydrogel and does not contain any collagen. The hydrogel polymer is biocompatible and completely resorbable after approximately one year. The HydroMARK breast biopsy site marker is available in direct puncture, Mammotome, Suros and SenoRx compatible delivery systems.
Faxitron Bioptics Faxitron is the world’s largest and only fully vertically integrated, dedicated cabinet x-ray company. With an installed base of over 7,000 systems in medical facilities and scientific and industrial research laboratories around the globe, Faxitron is the pioneer and industry standard in cabinet x-ray systems for specimen radiography, research, and NDT applications. For more than 40 years, Faxitron has defined cabinet x-ray by developing x-ray sensor technology and innovative systems to meet the evolving needs of our customers.
Devicor - Mammotome Our Mammotome® Biopsy System is a complete system for breast tissue sampling and management. Compatible with multiple imaging modalities, the Mammotome® Biopsy System enables breast biopsy to be performed under mammography, ultrasound or MRI. Mammotome offers tissue markers to mark the biopsy site for follow-up observations. As the global market leader in vacuum-assisted breast biopsy Mammotome is proud to present its newest biopsy system. Be excited to get trained on our product revolution!
Philips Healthcare

At Philips, we try to simplify healthcare through combining our unique clinical expertise with human insights to develop innovations that ultimately help to improve the quality of people’s lives.

With a growing presence in cardiology, oncology, and women’s health, we focus on the fundamental health problems with which people are confronted, such as congestive heart failure, lung and breast cancers and coronary artery disease. Our focus is to deliver value throughout the complete cycle of care: from disease prevention to screening and diagnosis through to treatment, monitoring and health management. Philips is dedicated to making an impact wherever care happens, within the hospital - critical care, emergency care and surgery – and, as importantly, in the home.


SonoCiné AWBUS is a highly effective Automated Whole Breast Ultrasound (AWBUS) system, invented and engineered to provide an adjunctive screening examination that maximizes early detection of mammographically occult breast cancers in women with dense breast tissue and women with breast implants. The patented technology integrates with all commercially available ultrasound scanners to provide a systematic, reproducible and fully documented whole breast screening examination. The SonoCiné AWBUS system utilizes a sophisticated 3-axis robotic ultrasound probe carrier and positioning gantry with angle sensors, accelerometers and gyroscopic motion control, to provide screening examinations that adapt to the breast size and shape of each individual woman, and enables the fastest possible recording of thousands of precise and equally spaced images of the entire breast. The high level of early cancer detection achievable with the SonoCiné AWBUS system is the result of a number of important characteristics. • The AWBUS system was designed to allow a technologist to perform and record the screening examination for later review by a radiologist. • The AWBUS system ensures precise computer controlled scanning of all breast tissue, as well as the lower axillary lymph nodes, in one comprehensive whole breast examination. • The AWBUS examinations are performed, recorded and reviewed with the highest possible image resolution to provide superior visualization of morphological tissue details, in order to maximize lesion detectability and minimize patient recalls. • SonoCiné’s patented Nipple Pad ensures unimpeded and artifact free visualization of all retro-areola tissue. • The Company’s CinéDetect workflow optimized, PACS compatible dynamic review software, enables rapid screening in a variable frame rate cine-loop format designed to maximize lesion conspicuity and simplify reporting. The AWBUS screening examination is pain, risk and radiation free, fully documented and quality controlled. In addition, the SonoCiné system can be interfaced and used in combination with all standard diagnostic ultrasound imaging systems, allowing its users to continuously take advantage of the latest developments in in ultrasound image quality and resolution.

Supersonic Imagine

Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine is an innovative, multinational medical imaging company dedicated to developing a revolutionary ultrasound system: the Aixplorer®. This system leverages a unique MultiWave™ technology that enables the user to detect, characterize and, in the future, treat palpable and non-palpable masses.

MissionNewsThe Breast CourseThe Breast Educational MaterialThe Breast TrainingContact Us